HIPEC treatment at the Henry Ford Cancer Institute was championed by the vision and generosity of Lindsey and Brett Finsilver, along with many of their family members and friends.
Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
An effective option for rare, complex cancer.
Hyperthermic intraperitoneal chemotherapy, or HIPEC, is a heated chemotherapy that is administered at the same time of a cytoreductive cancer (tumor-removing) surgery to treat rare or complex cancers that spread to the lining of the abdomen.
This innovative but aggressive treatment targets and destroys microscopic cancer cells that cannot be seen by the human eye. Destroying these cells can prevent them from later coming back as new cancer tumors.
HIPEC can be an effective option for certain cancers that spread to the lining of your abdomen, including, but not limited to:
- Appendiceal cancers
- Metastatic colorectal cancers
- Metastatic gastric cancers
- Certain ovarian cancers
As we do for all our patients, your treatment is specifically tailored to your individual condition. Your multidisciplinary cancer care team will discuss with you the treatment options and determine with you the best approach.
HIPEC is a two-pronged treatment approach: Cytoreductive surgery is first performed to remove visible cancer cells in the abdominal cavity. The abdominal cavity is then administered heated chemotherapy for approximately two hours.
This method of chemotherapy has several advantages:
- Enhances the chemotherapy’s absorption in the abdominal area
- Minimizes the rest of the body’s exposure to chemotherapy
- Directly targets microscopic cancer cells that are not visible to the human eye
Our multidisciplinary HIPEC team is your partner in care. Our team comprises more than 30 members, including specialty-trained surgical oncologists, medical oncologists, anesthesiologists, nurse navigators and other support staff that work together with you to determine whether you may be a candidate for HIPEC.